Enantioselectivity in Candida antarctica lipase B: a molecular dynamics study.

PubWeight™: 0.92‹?›

🔗 View Article (PMC 2373953)

Published in Protein Sci on February 01, 2001

Authors

S Raza1, L Fransson, K Hult

Author Affiliations

1: Department of Biotechnology, Royal Institute of Technology, SE-100 44 Stockholm, Sweden.

Articles by these authors

Ochratoxin A as the cause of spontaneous nephropathy in fattening pigs. Appl Environ Microbiol (1978) 1.86

A spectrophotometric procedure, using carboxypeptidase A, for the quantitative measurement of ochratoxin A. J Assoc Off Anal Chem (1976) 1.84

The absorption of cimetidine before and during maintenance treatment with cimetidine and the influence of a meal on the absorption of cimetidine--studies in patients with peptic ulcer disease. Br J Clin Pharmacol (1979) 1.59

Ochratoxin A in pig blood: method of analysis and use as a tool for feed studies. Appl Environ Microbiol (1979) 1.56

Production of NADPH in the mannitol cycle and its relation to polyketide formation in Alternaria alternata. Eur J Biochem (1978) 1.50

A common methylenetetrahydrofolate reductase gene mutation and longevity. Atherosclerosis (1998) 1.50

Crystallographic and molecular-modeling studies of lipase B from Candida antarctica reveal a stereospecificity pocket for secondary alcohols. Biochemistry (1995) 1.47

Degradation of ochratoxin A by a ruminant. Appl Environ Microbiol (1976) 1.39

On the interfacial activation of Candida antarctica lipase A and B as compared with Humicola lanuginosa lipase. Biochim Biophys Acta (1995) 1.37

Molecular dynamics simulations of an enzyme surrounded by vacuum, water, or a hydrophobic solvent. Biophys J (1994) 1.28

The distribution of the NADPH regenerating mannitol cycle among fungal species. Arch Microbiol (1980) 1.26

Biosynthesis of heparin. 3. Formation of iduronic acid residues. J Biol Chem (1974) 1.20

Expression in Pichia pastoris of Candida antarctica lipase B and lipase B fused to a cellulose-binding domain. Protein Expr Purif (2001) 1.13

Spontaneous occurrence of ochratoxin residues in kidneys of fattening pigs. Zentralbl Veterinarmed A (1977) 1.11

The role of Glu87 and Trp89 in the lid of Humicola lanuginosa lipase. Protein Eng (1996) 1.08

The co-polymeric structure of pig skin dermatan sulphate. Distribution of L-iduronic acid sulphate residues in co-polymeric chains. Biochem J (1975) 1.07

Ochratoxin A in blood from slaughter pigs in Sweden: use in evaluation of toxin content of consumed feed. Appl Environ Microbiol (1980) 1.05

Molecular modeling of the enantioselectivity in lipase-catalyzed transesterification reactions. Biophys J (1998) 1.05

The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function. Br J Clin Pharmacol (1982) 1.04

Improved enantioselectivity of a lipase by rational protein engineering. Chembiochem (2001) 1.04

Toxicokinetics of ochratoxin A in several species and its plasma-binding properties. J Appl Toxicol (1989) 0.98

Computer modeling of substrate binding to lipases from Rhizomucor miehei, Humicola lanuginosa, and Candida rugosa. Protein Sci (1994) 0.98

Stable linker peptides for a cellulose-binding domain-lipase fusion protein expressed in Pichia pastoris. Protein Eng (2001) 0.95

Rational design of enantioselective enzymes requires considerations of entropy. Protein Sci (2001) 0.95

Regulation and metabolic background of polyketide formation. I. Effects of (-)-hydroxycitrate and metabolic roles of citrate and malate in fatty acid and polyketide formations. Acta Chem Scand B (1976) 0.92

Mycotoxic porcine nephropathy and spontaneous occurrence of ochratoxin A residues in kidneys and blood of Polish swine. Appl Environ Microbiol (1984) 0.91

Ochratoxin A in blood of slaughter pigs. Nord Vet Med (1985) 0.88

Penicillium verrucosum in feed of ochratoxin A positive swine herds. Mycopathologia (1991) 0.87

The role of arginines in stabilizing the active open-lid conformation of Rhizomucor miehei lipase. Lipids (1993) 0.87

A structural basis for enantioselective inhibition of Candida rugosa lipase by long-chain aliphatic alcohols. Protein Sci (1996) 0.87

Theoretical studies of Rhizomucor miehei lipase activation. Protein Eng (1993) 0.87

Ochratoxin A in cow's milk and in human milk with corresponding human blood samples. J AOAC Int (1993) 0.86

Lipases from Rhizomucor miehei and Humicola lanuginosa: modification of the lid covering the active site alters enantioselectivity. J Protein Chem (1993) 0.86

Kinetics of acyl transfer reactions in organic media catalysed by Candida antarctica lipase B. Biochim Biophys Acta (1995) 0.86

Pharmacokinetics of cimetidine and its sulphoxide metabolite during haemodialysis. Eur J Clin Pharmacol (1982) 0.85

Trp89 in the lid of Humicola lanuginosa lipase is important for efficient hydrolysis of tributyrin. Lipids (1994) 0.85

Mass transport limitations reduce the effective stereospecificity in enzyme-catalyzed kinetic resolution. Org Lett (2000) 0.85

Probing a functional role of Glu87 and Trp89 in the lid of Humicola lanuginosa lipase through transesterification reactions in organic solvent. J Protein Chem (1995) 0.84

Variations in the chondroitin sulfate-protein linkage region of aggrecans from bovine nasal and human articular cartilages. J Biol Chem (1996) 0.84

Ochratoxin A in rice cultivars after inoculation of Penicillium verrucosum. Nat Toxins (1998) 0.83

Levels of ochratoxin A in blood from Norwegian and Swedish blood donors and their possible correlation with food consumption. Food Chem Toxicol (2001) 0.83

Surfactant interference on lipase catalysed reactions in microemulsions. J Chem Technol Biotechnol (1992) 0.83

Ochratoxin A in human serum samples collected in southern Italy from healthy individuals and individuals suffering from different kidney disorders. Nat Toxins (1994) 0.82

Human exposure to ochratoxin A in areas of Yugoslavia with endemic nephropathy. J Environ Pathol Toxicol Oncol (1991) 0.80

Gaschromatography of clemastine. A study of plasma kinetics and biological effect. Arzneimittelforschung (1978) 0.80

Intratracheal exposure of rats to Aspergillus fumigatus spores isolated from sawmills in Sweden. Appl Environ Microbiol (1989) 0.79

Spontaneous occurrence of ochratoxin A residues in porcine kidney and serum samples in Poland. Appl Environ Microbiol (1985) 0.79

Possible sources of ochratoxin A in human blood in Poland. IARC Sci Publ (1991) 0.78

High affinity binding of ochratoxin A to plasma constituents. Biochem Int (1984) 0.78

Placental and lactational transfer of ochratoxin A in rats. Nat Toxins (1998) 0.78

Tremorgenic mycotoxins from Aspergillus fumigatus as a possible occupational health problem in sawmills. Appl Environ Microbiol (1987) 0.78

Screening for ochratoxin A in blood by flow injection analysis. J Appl Toxicol (1984) 0.78

Creation of an enantioselective hydrolase by engineered substrate-assisted catalysis. J Am Chem Soc (2001) 0.77

Human exposure to ochratoxin A. IARC Sci Publ (1991) 0.77

Responses of glomerular filtration, renal blood flow and salt-water handling to acute cardioselective and non-selective beta-adrenoceptor blockade in essential hypertension. Eur J Clin Pharmacol (1989) 0.77

Ochratoxin A in blood and its pharmacokinetic properties. Food Chem Toxicol (1992) 0.77

Plasma ochratoxin A levels in three Swedish populations surveyed using an ion-pair HPLC technique. Food Addit Contam (1991) 0.77

Transfer of ochratoxin A from lactating rats to their offspring: a short-term study. Nat Toxins (1993) 0.77

Synthesis of 14C-ochratoxin A and 14C-ochratoxin B and a comparative study of their distribution in rats using whole body autoradiography. Pharmacol Toxicol (1992) 0.77

An active-site titration method for lipases. Biochim Biophys Acta (2000) 0.77

Assessment of arterial and venous circulation in upper and lower extremities by venous occlusion strain gauge plethysmography. Normal values and reproducibility. Vasa (1989) 0.77

Ochratoxin A in swine blood used for evaluation of cereal handling procedures. Zentralbl Veterinarmed B (1990) 0.76

Toxicokinetics of ochratoxin A in rat following intratracheal administration. Nat Toxins (1995) 0.76

Conversion of ochratoxin C into ochratoxin A in vivo. Appl Environ Microbiol (1984) 0.76

Ochratoxin A as a suppressor of mitogen-induced blastogenesis of porcine blood lymphocytes. Acta Vet Scand (1988) 0.76

Analysis of ochratoxin B alone and in the presence of ochratoxin A, using carboxypeptidase A. Appl Environ Microbiol (1977) 0.75

Distribution of 14C-ochratoxin A and 14C-ochratoxin B in rats: a comparison based on whole-body autoradiography. IARC Sci Publ (1991) 0.75

Carbon-14-ochratoxin A distribution in the Japanese quail (Coturnix coturnix japonica) monitored by whole body autoradiography. Poult Sci (1988) 0.75

The relationship between the transfer factor obtained at rest, and arterial oxygen tension during exercise, in patients with miscellaneous pulmonary diseases. J Intern Med (1992) 0.75

Enhanced stereoselectivity in pig liver esterase catalysed diester hydrolysis. The role of a competitive nucleophile. Bioorg Med Chem (1994) 0.75

Hemodynamic effects at rest and during exercise of combined alpha/beta-receptor blockade and of beta-receptor blockade alone in patients with ischemic heart disease. J Cardiovasc Pharmacol (1987) 0.75

Acute effects of combined alpha/beta-adrenoceptor blockade v combined beta-receptor and slow channel calcium blockade in ischemic heart disease complicated by hypertension. Hemodynamic and adrenergic responses. Am J Hypertens (1991) 0.75

Tremorgenic effects of mould extracts isolated in wood industry tested in rats. Arh Hig Rada Toksikol (1988) 0.75

Distribution of 14C-ochratoxin A in the mouse monitored by whole-body autoradiography. Pharmacol Toxicol (1988) 0.75

Enzyme-linked immunosorbent assay for analysis of ochratoxin A in human plasma samples using antibodies raised against a new ochratoxin-protein conjugate. IARC Sci Publ (1991) 0.75

Distribution of 14C-ochratoxin A in the rainbow trout (Salmo gairdneri). Acta Pharmacol Toxicol (Copenh) (1986) 0.75

Hemodynamic and adrenergic effects of combined alpha/beta-receptor blockade versus combined beta-receptor and slow channel calcium blockade in patients with ischemic heart disease. Int J Cardiol (1989) 0.75